A 31-year-old woman with autoimmune hepatitis (AIH) diagnosed 6 years ago is planning her first pregnancy. She has been in complete biochemical remission for 2 years on azathioprine 100 mg/day and prednisolone 5 mg/day. She has no cirrhosis or portal hypertension. She is concerned about foetal exposure to immunosuppressive therapy and asks whether she should stop her medication before attempting conception.